RNA
Atrium Therapeutics, Inc.
8.40$
+1.6%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2011 | 2012 | 2013 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | 81.4% | 98.7% | 99.3% | 96.2% | 97.5% | 97.3% | 98.6% | 98.0% | |
| 74.4% | 86.1% | 90.6% | 77.6% | 97.6% | 98.3% | 74.9% | 53.3% | 29.4% | 14.1% | 97.0% | |
| – | – | – | 77.6% | 97.6% | 98.3% | 94.8% | 95.6% | 94.7% | 96.0% | 97.0% | |
| – | – | – | – | 0.8% | 0.4% | 0.2% | 0.6% | 1.4% | 1.8% | 4.5% | |
| – | – | – | – | 0.0% | -0.4% | -0.2% | 0.0% | -1.2% | – | – | |
| 12.4% | 5.1% | 2.4% | 17.6% | 0.7% | 0.6% | 3.6% | 2.3% | – | – | – | |
| 3.6% | 1.8% | 0.8% | – | – | – | – | – | – | – | – | |
| 89.6% | 67.1% | 30.4% | 1,132.9% | 167.4% | 8.3% | 10.8% | 9.5% | 20.3% | 8.9% | 25.5% | |
| 47.3% | 25.8% | 10.0% | 115.9% | 10.6% | 4.4% | 6.9% | 8.1% | 12.8% | 6.3% | 15.0% | |
| – | – | – | 69.0% | 2.9% | 2.3% | 0.4% | 0.5% | 0.6% | 0.2% | 1.3% | |
| 10.0% | 5.0% | 2.1% | 39.3% | 2.4% | 2.3% | 0.7% | 0.7% | 1.4% | 0.5% | 1.6% | |
| 9.9% | 13.1% | 8.4% | 190.3% | 1.8% | – | – | – | – | – | – | |
| 10.4% | 32.9% | 69.6% | -1,032.9% | -67.4% | 91.7% | 89.2% | 90.5% | 79.7% | 91.1% | 74.5% | |
| – | – | – | -1,043.6% | -22.9% | -19.9% | -43.2% | -56.1% | -90.8% | -57.1% | -566.8% | |
| – | – | – | 519.4% | 38.7% | 6.5% | 9.7% | 8.2% | 11.6% | 7.1% | 6.1% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.